Successful treatment of pityriasis rubra pilaris with guselkumab: Serum CCL20 as a potential marker for the disease activity.

Nagai, Hiroshi; Jimbo, Haruki; Matsuura, Shoko; Tatsuoka, Saori; Shiraki, Erina; Nishigori, Chikako

Nagai, Hiroshi; Jimbo, Haruki; Matsuura, Shoko; Tatsuoka, Saori; Shiraki, Erina; Nishigori, Chikako.

Afiliación

Nagai H; Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan.
Jimbo H; Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan.
Matsuura S; Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan.
Tatsuoka S; Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan.
Shiraki E; Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan.
Nishigori C; Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan.

Dermatol Ther ; 33(6): e14403, 2020 11.

Article en En | MEDLINE | ID: mdl-33044038

Asunto(s)

Anticuerpos Monoclonales Humanizados/uso terapéutico; Pitiriasis Rubra Pilaris; Quimiocina CCL20/sangre; Femenino; Humanos; Persona de Mediana Edad; Pitiriasis Rubra Pilaris/diagnóstico; Pitiriasis Rubra Pilaris/tratamiento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pitiriasis Rubra Pilaris / Anticuerpos Monoclonales Humanizados Tipo de estudio: Diagnostic_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Dermatol Ther Asunto de la revista: DERMATOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google